產(chǎn)品詳情
簡單介紹：
Anti-EVER2抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-EVER2抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-EVER2
Cat. Number:
Anti-EVER2抗體KL-13116R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Transmembrane channel-like protein 8 (TMC8), also known as Epidermodysplasia verruciformis protein 2 (EVER2), is a 726 amino acid member of the TMC family of proteins. Localized to the endoplasmic reticulum membrane, TMC8 is thought to form a transmembrane channel-like protein with eight predicted transmembrane Anti-EVER2抗體domains and three leucine zipper motifs. Mutations in the genes encoding TMC8 and TMC6, another member of the TMC family, have been shown to cause epidermodysplasia verruciformis (EV), an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. Infection by HPVs lead to persistent wart-like or macular lesions. TMC8 is expressed in placenta, prostate and testis, and three named isoforms exist as a result of alternative splicing events.
Also known as:
epidermodysplasia verruciformis 2; Anti-EVER2抗體Epidermodysplasia verruciformis protein 2; EV2; EVIN2; FLJ40668; FLJ43684; MGC102701; MGC40121; TMC8; Transmembrane channel like protein 8; TMC8_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Anti-EVER2抗體Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human EVER2/TM.
●
Predicted Molecular Weight: 82kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-EVER2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-EVER2抗體
Optimal working dilutions must be determined by the end user.
kl547Hu01 吲哚胺2,3-雙加氧酶(IDO)多克隆抗體 Polyclonal Antibody to Indoleamine-2,3-Dioxygenase (IDO)
kl547Mu01 吲哚胺2,3-雙加氧酶(IDO)多克隆抗體 Polyclonal Antibody to Indoleamine-2,3-Dioxygenase (IDO)
kl547Ra01 吲哚胺2,3-雙加氧酶(IDO)多克隆抗體 Polyclonal Antibody to Indoleamine-2,3-Dioxygenase (IDO)
kl550Hu01 脊髓灰質(zhì)炎病毒受體(PVR)多克隆抗體 Polyclonal Antibody to Poliovirus Receptor (PVR)
kl551Hu01 骨髓基質(zhì)細(xì)胞抗原1(BST1)多克隆抗體 Polyclonal Antibody to Bone Marrow Stromal Cell Antigen 1 (BST1)
kl555Hu01 解整合素金屬蛋白酶17(ADAM17)多克隆抗體 Polyclonal Antibody to A Disintegrin And Metalloprotease 17 (ADAM17)
kl559Hu01 絲切蛋白1(CFL1)多克隆抗體 Polyclonal Antibody to Cofilin 1, Non Muscle (CFL1)
kl560Hu01 ****β(LTβ)多克隆抗體 Polyclonal Antibody to Lymphotoxin Beta (LTb)
kl562Hu01 殺傷細(xì)胞**球蛋白樣受體3DL1(KIR3DL1)多克隆抗體 Polyclonal Antibody to Killer Cell Immunoglobulin Like Receptor 3DL1 (KIR3DL1)
kl564Hu01 干擾素調(diào)節(jié)因子1(IRF1)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 1 (IRF1)
kl564Mu01 干擾素調(diào)節(jié)因子1(IRF1)多克隆抗體 Polyclonal Antibody to Interferon Regulatory Factor 1 (IRF1)
kl566Hu01 肝型脂肪酸結(jié)合蛋白(FABP1)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 1, Liver (FABP1)
kl566Po01 肝型脂肪酸結(jié)合蛋白(FABP1)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 1, Liver (FABP1)
kl567Hu01 細(xì)胞間粘附分子4(ICAM4)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 4 (ICAM4)
kl568Hu01 血小板因子4V1(PF4V1)多克隆抗體 Polyclonal Antibody to Platelet Factor 4 Variant 1 (PF4V1)
kl570Hu01 粒細(xì)胞趨化蛋白2(GCP2)多克隆抗體 Polyclonal Antibody to Granulocyte Chemotactic Protein 2 (GCP2)
kl570Ra01 粒細(xì)胞趨化蛋白2(GCP2)多克隆抗體 Polyclonal Antibody to Granulocyte Chemotactic Protein 2 (GCP2)
